Mass Ave Global’s Edwards Lifesciences EW Stock Holding History

Mass Ave Global’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$1.38M	Buy	+18,535	New	+$1.43M	0.4%	28

Other funds holding EW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Mass Ave Global's EW Position: Q4 2022 in Review

Mass Ave Global opened a new position in Edwards Lifesciences (EW) in Q4 2022: 18,535 shares worth $1.38M. The stake represents 0.4% of the portfolio and ranks #28 among its holdings.

1,228 funds tracked by Wall St. Rank hold EW as of Q4 2022.

Mass Ave Global held 18,535 shares of Edwards Lifesciences worth $1.38M as of Q4 2022.
Edwards Lifesciences was a new Mass Ave Global position in Q4 2022.
Edwards Lifesciences made up 0.4% of Mass Ave Global's portfolio in Q4 2022, its #28 holding.
1,228 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2022.

Based on Mass Ave Global's 13F filing for Q4 2022, filed 14 Feb 2023.